<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
SEPTEMBER 26, 2000
TRIPATH IMAGING, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-22885 56-1995728
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
780 PLANTATION DRIVE, BURLINGTON, NORTH CAROLINA 27215
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code:
(336) 222-9707
<PAGE> 2
ITEM 5. OTHER EVENTS.
TriPath Imaging, Inc. announced that it has signed a Securities Purchase
Agreement (the "Agreement") with Roche pursuant to which a wholly owned
subsidiary of Roche will purchase TriPath common stock. Filed herewith as
Exhibit 99.1 is a copy of a press release that was issued October 2, 2000
describing the Agreement. Filed herewith as Exhibit 99.2 is a copy of the
Agreement.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) EXHIBITS.
99.1 Press release issued by the registrant on October 2, 2000.
99.2 Securities Purchase Agreement, dated September 26, 2000, by and among
TriPath Imaging, Inc., Roche International Ltd. and Certain
Stockholders of TriPath.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: October 2, 2000 TRIPATH IMAGING, INC.
By: /s/ Paul R. Sohmer
-----------------------------------------
Paul R. Sohmer, M.D.
President and Chief Executive Officer
<PAGE> 3
EXHIBIT INDEX
<TABLE>
<CAPTION>
EXHIBIT
NO. DESCRIPTION
------- -----------
<S> <C>
99.1 Press release issued by the registrant on October 2, 2000.
99.2 Securities Purchase Agreement, dated September 26, 2000, by and among
TriPath Imaging, Inc., Roche International Ltd. and Certain
Stockholders of TriPath.
</TABLE>
